139 related articles for article (PubMed ID: 29403558)
1. Potential biological process of X-linked inhibitor of apoptosis protein in renal cell carcinoma based upon differential protein expression analysis.
Chen C; Zhao SC; Yang WZ; Chen ZP; Yan Y
Oncol Lett; 2018 Jan; 15(1):821-832. PubMed ID: 29403558
[TBL] [Abstract][Full Text] [Related]
2. Isobaric tags for relative and absolute quantitation-based quantitative proteomic analysis of X-linked inhibitor of apoptosis and H2AX in etoposide-induced renal cell carcinoma apoptosis.
Liu TS; Chen C; Zhou B; Xia BW; Chen ZP; Yan Y
Chin Med J (Engl); 2019 Dec; 132(24):2941-2949. PubMed ID: 31855962
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis.
Mizutani Y; Nakanishi H; Li YN; Matsubara H; Yamamoto K; Sato N; Shiraishi T; Nakamura T; Mikami K; Okihara K; Takaha N; Ukimura O; Kawauchi A; Nonomura N; Bonavida B; Miki T
Int J Oncol; 2007 Apr; 30(4):919-25. PubMed ID: 17332931
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-212 inhibits the proliferation, migration and invasion of renal cell carcinoma by targeting X-linked inhibitor of apoptosis protein (XIAP).
Gu C; Wang Z; Jin Z; Li G; Kou Y; Jia Z; Yang J; Tian F
Oncotarget; 2017 Nov; 8(54):92119-92133. PubMed ID: 29190902
[TBL] [Abstract][Full Text] [Related]
5. XIAP impairs mitochondrial function during apoptosis by regulating the Bcl-2 family in renal cell carcinoma.
Chen C; Liu TS; Zhao SC; Yang WZ; Chen ZP; Yan Y
Exp Ther Med; 2018 May; 15(5):4587-4593. PubMed ID: 29731840
[TBL] [Abstract][Full Text] [Related]
6. X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells.
Roa WH; Chen H; Fulton D; Gulavita S; Shaw A; Th'ng J; Farr-Jones M; Moore R; Petruk K
Clin Invest Med; 2003 Oct; 26(5):231-42. PubMed ID: 14596484
[TBL] [Abstract][Full Text] [Related]
7. The Role of cIAP1 and XIAP in Apoptosis Induced by Tumor Necrosis Factor Alpha in Esophageal Squamous Cell Carcinoma Cells.
Hikami S; Shiozaki A; Kitagawa-Juge M; Ichikawa D; Kosuga T; Konishi H; Komatsu S; Fujiwara H; Okamoto K; Otsuji E
Dig Dis Sci; 2017 Mar; 62(3):652-659. PubMed ID: 28050781
[TBL] [Abstract][Full Text] [Related]
8. XIAP underlies apoptosis resistance of renal cell carcinoma cells.
Yang WZ; Zhou H; Yan Y
Mol Med Rep; 2018 Jan; 17(1):125-130. PubMed ID: 29115633
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Par-4 enhances thapsigargin-induced apoptosis via down-regulation of XIAP and inactivation of Akt in human renal cancer cells.
Lee TJ; Lee JT; Kim SH; Choi YH; Song KS; Park JW; Kwon TK
J Cell Biochem; 2008 Feb; 103(2):358-68. PubMed ID: 18041764
[TBL] [Abstract][Full Text] [Related]
10. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.
Vucic D; Franklin MC; Wallweber HJ; Das K; Eckelman BP; Shin H; Elliott LO; Kadkhodayan S; Deshayes K; Salvesen GS; Fairbrother WJ
Biochem J; 2005 Jan; 385(Pt 1):11-20. PubMed ID: 15485396
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death.
Suzuki Y; Nakabayashi Y; Takahashi R
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8662-7. PubMed ID: 11447297
[TBL] [Abstract][Full Text] [Related]
12. The X-linked inhibitor of apoptosis protein (XIAP) is involved in melanoma invasion by regulating cell migration and survival.
Ayachi O; Barlin M; Broxtermann PN; Kashkar H; Mauch C; Zigrino P
Cell Oncol (Dordr); 2019 Jun; 42(3):319-329. PubMed ID: 30778852
[TBL] [Abstract][Full Text] [Related]
13. The novel phospholipase C activator, m-3M3FBS, induces apoptosis in tumor cells through caspase activation, down-regulation of XIAP and intracellular calcium signaling.
Jung EM; Lee TJ; Park JW; Bae YS; Kim SH; Choi YH; Kwon TK
Apoptosis; 2008 Jan; 13(1):133-45. PubMed ID: 18060503
[TBL] [Abstract][Full Text] [Related]
14. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy.
Yang L; Cao Z; Yan H; Wood WC
Cancer Res; 2003 Oct; 63(20):6815-24. PubMed ID: 14583479
[TBL] [Abstract][Full Text] [Related]
15. Identification of hub genes associated with RNAi-induced silencing of XIAP through targeted proteomics approach in MCF7 cells.
Gholizadeh MA; Shamsabadi FT; Yamchi A; Golalipour M; Jhingan GD; Shahbazi M
Cell Biosci; 2020; 10():78. PubMed ID: 32537125
[TBL] [Abstract][Full Text] [Related]
16. Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells.
Yano K; Horinaka M; Yoshida T; Yasuda T; Taniguchi H; Goda AE; Wakada M; Yoshikawa S; Nakamura T; Kawauchi A; Miki T; Sakai T
Int J Oncol; 2011 Feb; 38(2):365-74. PubMed ID: 21165560
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting XIAP expression by RNAi to inhibit proliferation and enhance radiosensitivity in laryngeal cancer cell line.
Wang R; Li B; Wang X; Lin F; Gao P; Cheng SY; Zhang HZ
Auris Nasus Larynx; 2009 Jun; 36(3):332-9. PubMed ID: 19013033
[TBL] [Abstract][Full Text] [Related]
18. Topotecan triggers apoptosis in p53-deficient cells by forcing degradation of XIAP and survivin thereby activating caspase-3-mediated Bid cleavage.
Tomicic MT; Christmann M; Kaina B
J Pharmacol Exp Ther; 2010 Jan; 332(1):316-25. PubMed ID: 19812371
[TBL] [Abstract][Full Text] [Related]
19. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
Asselin E; Mills GB; Tsang BK
Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
[TBL] [Abstract][Full Text] [Related]
20. Activation of the MEK/MAPK pathway is involved in bryostatin1-induced monocytic differenciation and up-regulation of X-linked inhibitor of apoptosis protein.
Lin H; Chen C; Li X; Chen BD
Exp Cell Res; 2002 Jan; 272(2):192-8. PubMed ID: 11777344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
